Skip to main content
Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.340
-0.265 (-16.51%)
At close: Nov 12, 2026, 4:00 PM EST
1.280
-0.060 (-4.48%)
After-hours: Nov 12, 2026, 7:59 PM EST

Fate Therapeutics Revenue

Fate Therapeutics had revenue of $4.75M in the twelve months ending September 30, 2026, down -33.45% year-over-year. In the year 2025, Fate Therapeutics had annual revenue of $6.65M, down -51.24%. That makes Fate Therapeutics the 40,159th largest company in the world by revenue and 5,323rd in the United States.

Revenue (ttm)
$4.75M
Revenue Growth
-33.45%
P/S Ratio
33.68
Revenue / Employee
$29,503
Employees
161
Market Cap
160.56M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20256.65M-6.99M-51.24%
Dec 31, 202413.63M-49.90M-78.55%
Dec 31, 202363.53M-32.77M-34.03%
Dec 31, 202296.30M40.45M72.44%
Dec 31, 202155.85M24.41M77.66%
Dec 31, 202031.43M20.75M194.33%
Dec 31, 201910.68M5.94M125.32%
Dec 31, 20184.74M634.00K15.44%
Dec 31, 20174.11M-296.00K-6.72%
Dec 31, 20164.40M1.97M81.08%
Dec 31, 20152.43M--
Dec 31, 2014---
Dec 31, 2013971.00K-1.70M-63.63%
Dec 31, 20122.67M1.50M128.21%
Dec 31, 20111.17M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Compugen75.93M
AC Immune23.75M
MediWound11.86M
Pyxis Oncology11.04M
Entrada Therapeutics3.98M
Sol-Gel Technologies1.80M
Korro Bio1.29M
Cartesian Therapeutics1.03M
Revenue Rankings

FATE News

More News